Post-Award Notice-Justification for MACSQuant Tyto cell sorter

Awarded Limited / Sole Source Justification Posted

Solicitation number
JA_NIAID_2082766
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
75N93021P01503 Federal contract award
Place of performance
California 95602, United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Limited/Sole Source Justification Notice from the National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a contract to Miltenyi Biotech, Inc. for the purchase of one MACSQuant Tyto Cell-Sorter for $2,082,766. The cell sorter will be used by the Flow Cytometry Unit to support COVID-19 research through downstream applications such as single cell genomics and CRISPR technologies. As only Miltenyi Biotech can meet the technical requirements for closed cartridge operation and BSL-3 compatibility needed to safely handle COVID-19 samples, this sole source award was justified.

Notice text

The Division of Intramural Research (DIR), Research Technologies Branch (RTB), Research Technologies Section (RTS) Flow Cytometry Unit (FCU) & Flow Cytometry Section (FCS) (collectively “Program”) provides intramural National Institute of Allergy and Infectious Diseases (NIAID) investigators with application-specific flow cytometric technologies, including instrumentation and multi-color analysis. In addition, the FCS provides training, consultation, method development, and analysis for experiments involving flow cytometry. This mission is accomplished through the efforts of staff with extensive flow cytometry experience and with the use of cell sorters and analyzers. Major goals are to provide access to state-of-the-art technologies, to help design and run experiments, to facilitate data interpretation, and to provide results that are of consistent high quality.

The Flow Cytometry Unit of the Research Technologies Branch requests the purchase of a MACSQuant Tyto Cell-sorter (“Tyto”) which is a high-speed cell analyzer that will be used for downstream applications such as single cell genomics and CRISPR technologies. The procurement of this high-performance cell analyzer will guarantee the optimal function and therefore reliable data of the flow cytometry analysis and sorting.  There is a growing need at RML for sorting fragile cells and bacteria.  Current sorting equipment has limitations with purity, viability and resolution.  The Tyto sorter will allow investigators very pure and viable cells for downstream applications such as single cell genomics and CRISPR technologies. This equipment will be important in conducting SARS-CoV-2/COVID-19 research and studies.

Reference attached Limited Source Justification. 

Awarded contract 75N93021P01503 to unknown vendor for unknown amount on 2021-09-24.

Files

File Type Posted
2082766 - J and A Addendum (COVID)_Redacted.pdf PDF
NIH Class JA Fully Signed.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Service agreement for the cytena f sight cell sorter base + two option year Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
Preventative Maintenance and Service Support for Miltenyi Biotec CliniMACS Plus Instruments Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity